Abstract:
:Lipodystrophy complications, including lipoatrophy (pathological fat loss) and metabolic complications, have emerged as important long-term toxicities associated with antiretroviral therapy in the current era. The wealth of data that has accumulated over the past 6 years has now clarified the contribution of specific antiretroviral drugs to the risk of these clinical endpoints, with evidence that lipoatrophy is strongly associated with the choice of nucleoside reverse transcriptase inhibitor therapy (specifically, stavudine and to a lesser extent zidovudine). The aetiological basis of metabolic complications of antiretroviral therapy has proven to be complex, in that the risk appears to be modulated by a number of lifestyle factors that have made the metabolic syndrome highly prevalent in the general population, with additional contributions from HIV disease status itself, as well as from individual drugs within the HIV protease inhibitor class. The currently licensed non-nucleoside reverse transcriptase inhibitor (NNRTI) drugs, efavirenz and nevirapine, have been proven to have a favourable safety profile in terms of lipodystrophy complications. However, it must be noted that NNRTI drugs also have individual toxicity profiles that must be accounted for when considering and/or monitoring their use in the treatment of HIV infection.
journal_name
Drug Safjournal_title
Drug safetyauthors
Nolan Ddoi
10.2165/00002018-200528120-00002keywords:
subject
Has Abstractpub_date
2005-01-01 00:00:00pages
1069-74issue
12eissn
0114-5916issn
1179-1942pii
28122journal_volume
28pub_type
杂志文章,评审相关文献
DRUG SAFETY文献大全abstract::Eosinophils play a pivotal role in the inflammatory pathology of asthma and have been the target of new biologic treatments for patients with eosinophilic asthma. Given the central role of interleukin (IL)-5 in the eosinophil lifecycle, several therapies directed against the IL-5 pathway have been developed, including...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-020-00926-3
更新日期:2020-05-01 00:00:00
abstract::An important role for the WHO Programme for International Drug Monitoring is to identify signals of international drug safety problems as early as possible. Since 1998, Bayesian Confidence Propagation Neural Network (BCPNN) data mining has been in routine use for screening of the WHO adverse reaction database, Vigibas...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200730070-00014
更新日期:2007-01-01 00:00:00
abstract::Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic options of cardiovascular diseases with recognized clinical and epidemiological impact, such as non-valvular atrial fibrillation (NVAF) and venous thromboembolism (VTE), and also in the preventive setting of orthopedic surgical pat...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.1007/s40264-016-0464-3
更新日期:2016-12-01 00:00:00
abstract:BACKGROUND:Pioglitazone is an antidiabetic drug that belongs to the thiazolidinedione (TZD) class of insulin-sensitizing agents. Adverse events to pioglitazone of potential severity are listed in the 'special warnings and special precautions for use' section of the pioglitazone summary of product characteristics (SPC),...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200932030-00005
更新日期:2009-01-01 00:00:00
abstract:BACKGROUND:For many regularly used drugs, evidence for safe use in pregnancy has not been established. Despite this, international studies have identified high levels of drug prescribing among pregnant women. OBJECTIVE:To investigate the patterns of prescribing of drugs to women who gave birth in Tayside, Scotland, in...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/11532330-000000000-00000
更新日期:2010-07-01 00:00:00
abstract::The electrocardiographic effects of ebastine and its active metabolite, carebastine, have been studied alone and in relevant drug-interaction studies in various patient populations. The overall cardiac tolerability of ebastine is excellent. In ebastine dose-ranging studies in adults and children, there were no meaning...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199921001-00009
更新日期:1999-01-01 00:00:00
abstract:INTRODUCTION:Evidence suggests the current verbal risk descriptors used to communicate side effect risk in patient information leaflets (PILs) are overestimated. OBJECTIVES:The aim was to establish how people understand the verbal risk descriptors recommended for use in PILs by the European Commission (EC), and altern...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-017-0542-1
更新日期:2017-08-01 00:00:00
abstract:BACKGROUND:There are no head-to-head randomized controlled trials comparing different direct oral anticoagulants (DOACs). Thus, we systematically reviewed and meta-analyzed observational studies assessing the comparative effectiveness and safety of DOACs for stroke prevention in patients with atrial fibrillation (AF). ...
journal_title:Drug safety
pub_type: 杂志文章,meta分析
doi:10.1007/s40264-019-00842-1
更新日期:2019-10-01 00:00:00
abstract::Pharmacovigilance is the science of monitoring the effects of medicinal products to identify and evaluate potential adverse reactions and provide necessary and timely risk mitigation measures. Intelligent automation technologies have a strong potential to automate routine work and to balance resource use across safety...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-020-01030-2
更新日期:2021-02-01 00:00:00
abstract::Safe and effective treatment of major depression, one of the most common comorbid conditions in individuals infected with HIV, significantly lowers morbidity and mortality from HIV disease. However, optimal treatment of both conditions is complicated by interactions between the disease processes as well as the pharmac...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200528090-00002
更新日期:2005-01-01 00:00:00
abstract:BACKGROUND:Automated disproportionality analysis of spontaneous reporting is increasingly used routinely. It can theoretically be influenced by a competition bias for signal detection owing to the presence of reports related to well-established drug-event associations. OBJECTIVE:The aim of the study was to explore the...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/BF03261981
更新日期:2012-10-01 00:00:00
abstract:BACKGROUND:Case reports have related the use of HMG-CoA reductase inhibitors ('statins') to Parkinson's disease (PD). Paradoxically, however, statins may have potentially beneficial effects on neurodegenerative diseases due to their anti-inflammatory properties. OBJECTIVE:To explore the risk of the development of PD i...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200831050-00004
更新日期:2008-01-01 00:00:00
abstract::Transdermal fentanyl is effective and well tolerated for the treatment of chronic pain caused by malignancy and non-malignant conditions when administered according to the manufacturer's recommendations. Compared with oral opioids, the advantages of transdermal fentanyl include a lower incidence and impact of adverse ...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200326130-00004
更新日期:2003-01-01 00:00:00
abstract::Although heart failure is predominantly caused by cardiovascular conditions such as hypertension, coronary heart disease and valvular heart disease, it can also be an adverse reaction induced by drug therapy. In addition, some drugs have the propensity to adversely affect haemodynamic mechanisms in patients with an al...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200629070-00003
更新日期:2006-01-01 00:00:00
abstract::The prevalence of pain is high in multimorbid patients and they can experience a multitude of painful conditions. The changes in physiology and homeostasis associated with multimorbidity and increasing age and the immature metabolism of neonates all increase the risk of toxicity from analgesics. Altered pharmacokineti...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199818060-00006
更新日期:1998-06-01 00:00:00
abstract:INTRODUCTION:The prevalence of polymorphisms among the metabolising enzymes and pharmacodynamic receptors relevant for the thiazolidinediones differs by ethnic group, a factor that may modify risk of adverse drug events. OBJECTIVE:The aim of the study was to determine if the risk of oedema or heart failure associated ...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-015-0318-4
更新日期:2015-09-01 00:00:00
abstract::The biochemistry of vitamin K metabolism and the role of vitamin K-dependent gamma-carboxylation of the vitamin K-dependent coagulation factors are now well understood. Likewise, there is a clear understanding of the role of oral anticoagulants in the inhibition of these coagulation factors. However, the effect of ora...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199309040-00004
更新日期:1993-10-01 00:00:00
abstract:INTRODUCTION:Electronic healthcare databases (EHDs) are used increasingly for post-marketing drug safety surveillance and pharmacoepidemiology in Europe and North America. However, few studies have examined the potential of these data sources in China. METHODS:Three major types of EHDs in China (i.e., a regional commu...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-017-0589-z
更新日期:2018-01-01 00:00:00
abstract::The New Zealand Intensive Medicines Monitoring Programme (IMMP) undertakes prospective observational cohort studies on selected new drugs in the early postmarketing period using prescription-event monitoring (PEM) methodology with the purpose of identifying signals of previously unrecognised ADRs and establishing risk...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200225060-00007
更新日期:2002-01-01 00:00:00
abstract::After initial enthusiasm, the use of monoamine oxidase inhibitors (MAOIs) has been limited by the wide range of MAOI-drug and MAOI-food interactions that are possible, particularly with sympathomimetic medications or tyramine-containing foods, resulting in hypertensive reactions. Despite their clinical benefits, this ...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199614040-00002
更新日期:1996-04-01 00:00:00
abstract:BACKGROUND:Atypical antipsychotics have been associated with metabolic abnormalities including impaired glucose metabolism, exacerbation of existing diabetes mellitus and new-onset type 2 diabetes. Not all atypical antipsychotic agents appear to have the same propensity to cause these complications. OBJECTIVE:To asses...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200730070-00004
更新日期:2007-01-01 00:00:00
abstract::There are 2 isoenzymes of cyclo-oxygenase (COX). There is a constitutive enzyme COX-1 which has a wide tissue distribution. In addition there is an inducible enzyme COX-2 which has a restricted tissue distribution. The inducible enzyme COX-2 is responsible for the generation of prostaglandins at sites of tissue inflam...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199615040-00003
更新日期:1996-10-01 00:00:00
abstract::Pharmacovigilance science has traditionally been a discipline focussed on the postmarketing or post-authorisation period, with due attention directed towards pre-clinical safety data, clinical trials and adverse events. As the biological sciences have evolved, pharmacovigilance has slowly shifted toward earlier, proac...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200629080-00003
更新日期:2006-01-01 00:00:00
abstract::This 'Erice Call for Change' is a report from a group of experts, patients and patient representatives who met in Erice in September 2019 following previous similar meetings after the original Erice Declaration (1996). The aim of the meeting was to discuss the challenge of causal complexity and individual variation in...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-020-00919-2
更新日期:2020-06-01 00:00:00
abstract:BACKGROUND:The availability of large-scale observational healthcare data allows for the active monitoring of safety of drugs, but research is needed to determine which statistical methods are best suited for this task. Recently, the Longitudinal Gamma Poisson Shrinker (LGPS) and Longitudinal Evaluation of Observational...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-013-0107-x
更新日期:2013-10-01 00:00:00
abstract::In August 2015, the US Food and Drug Administration (FDA) made the controversial decision to approve flibanserin (Addyi®) for women experiencing hypoactive sexual desire disorder. A number of factors contributed to disagreements regarding the FDA's decision, including the product's two prior failed FDA reviews, the un...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.1007/s40264-015-0389-2
更新日期:2016-05-01 00:00:00
abstract::The available antihyperlipidaemic drugs are generally safe and effective, and major systemic adverse effects are uncommon. However, because of their complex mechanisms of action, careful monitoring is required to identify and correct potential drug interactions. Bile acid sequestrants are the most difficult of these a...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-199411050-00002
更新日期:1994-11-01 00:00:00
abstract:BACKGROUND:The detection of new drug safety signals is of growing importance with ever more new drugs becoming available and exposure to medicines increasing. The task of evaluating information relating to safety lies with national agencies and, for international data, with the World Health Organization Programme for I...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200023060-00004
更新日期:2000-12-01 00:00:00
abstract:BACKGROUND AND OBJECTIVE:Rosuvastatin is a lipid-lowering drug, the newest of a class of drugs called HMG-CoA reductase inhibitors, or 'statins', launched in the UK in March 2003. Our objective was to monitor the post-marketing safety of this drug, prescribed in primary care in England, using prescription-event monitor...
journal_title:Drug safety
pub_type: 杂志文章
doi:10.2165/00002018-200730020-00005
更新日期:2007-01-01 00:00:00
abstract::The introduction of MedDRA, the Medical Dictionary for Regulatory Activities, as a standardised terminology may have a major impact on the performance of risk management. Thus, MedDRA is likely to have an important effect on the analysis of clinical trial safety data. Review of the most commonly used terms in clinical...
journal_title:Drug safety
pub_type: 杂志文章,评审
doi:10.2165/00002018-200427080-00010
更新日期:2004-01-01 00:00:00